Dimensional Fund Advisors
ZNTL icon

Dimensional Fund Advisors’s Zentalis Pharmaceuticals ZNTL Stock Holding History

Dimensional Fund Advisors’s Portfolio ZNTL Stock Details ZNTL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$634K Buy
272,034
+175,771
+183% +$454K ﹤0.01% 2914
2025
Q4 		$130K Sell
96,263
-88,769
-48% -$129K ﹤0.01% 3123
2025
Q3 		$279K Sell
185,032
-150,934
-45% -$226K ﹤0.01% 3076
2025
Q2 		$390K Sell
335,966
-111,434
-25% -$147K ﹤0.01% 3033
2025
Q1 		$712K Sell
447,400
-57,606
-11% -$124K ﹤0.01% 2945
2024
Q4 		$1.53M Sell
505,006
-638
-0.1% -$2.09K ﹤0.01% 2846
2024
Q3 		$1.86M Sell
505,644
-121,019
-19% -$440K ﹤0.01% 2794
2024
Q2 		$2.56M Sell
626,663
-96,993
-13% -$1.08M ﹤0.01% 2701
2024
Q1 		$11.4M Sell
723,656
-377
-0.1% -$5.19K ﹤0.01% 2258
2023
Q4 		$11M Buy
724,033
+239,714
+49% +$3.5M ﹤0.01% 2286
2023
Q3 		$9.72M Buy
484,319
+110,415
+30% +$2.8M ﹤0.01% 2276
2023
Q2 		$10.5M Buy
373,904
+51,107
+16% +$1.23M ﹤0.01% 2234
2023
Q1 		$5.55M Buy
322,797
+189,766
+143% +$3.84M ﹤0.01% 2453
2022
Q4 		$2.68K Buy
133,031
+98,683
+287% +$2.12M ﹤0.01% 2648
2022
Q3 		$744K Sell
34,348
-37,362
-52% -$1.02M ﹤0.01% 2961
2022
Q2 		$2.01M Sell
71,710
-19,792
-22% -$524K ﹤0.01% 2736
2022
Q1 		$4.22M Buy
+91,502
New +$4.94M ﹤0.01% 2585

Other funds holding ZNTL

5VM
5AM Venture Management San Francisco, California $360M AUM 345.76% 1-Year Est. Return
SCM
Squadron Capital Management Westmont, Illinois $273M AUM
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $661M AUM 299.97% 1-Year Est. Return

Dimensional Fund Advisors's ZNTL Position: Q1 2026 in Review

Dimensional Fund Advisors increased its Zentalis Pharmaceuticals (ZNTL) stake by 183% in Q1 2026, buying an estimated $454K and bringing the position to 272,034 shares worth $634K. The position accounts for ﹤0.01% of the portfolio, ranked #2914.

Dimensional Fund Advisors first reported a position in ZNTL in Q1 2022 and has held it in 17 quarters since. The position peaked at $11.4M in Q1 2024. 102 funds tracked by Wall St. Rank hold ZNTL as of Q1 2026.

  • Dimensional Fund Advisors held 272,034 shares of Zentalis Pharmaceuticals worth $634K as of Q1 2026.
  • Dimensional Fund Advisors bought 175,771 Zentalis Pharmaceuticals shares in Q1 2026, an estimated $454K.
  • Zentalis Pharmaceuticals made up ﹤0.01% of Dimensional Fund Advisors's portfolio in Q1 2026, its #2914 holding.
  • Dimensional Fund Advisors first reported a position in Zentalis Pharmaceuticals in Q1 2022 and has held it in 17 quarters since.
  • Dimensional Fund Advisors's Zentalis Pharmaceuticals position peaked at $11.4M in Q1 2024.
  • 102 funds tracked by Wall St. Rank held Zentalis Pharmaceuticals as of Q1 2026.

Based on Dimensional Fund Advisors's 13F filing for Q1 2026, filed 7 May 2026.